Published On:April 2 2014
Story Viewed 1049 Times
Aurobindo Pharma completes acquisition of select Western European Businesses of Actavis.
Aurobindo Pharma has completed the acquisition of certain commercial operations in Western Europe from Actavis plc. The agreement to acquire the Actavis operations was announced in January 2014. The company acquired personnel, commercial infrastructure, products, marketing authorizations and dossier license rights in seven European countries. Actavis and Aurobindo have also entered into a long term commercial and supply arrangement.
Following receipt of clearances from competent authorities, Aurobindo now intends to combine the strength of both enterprises (including its vertically integrated platform and existing commercial infrastructure) in these markets and to identify and maximize all opportunities to improve performance.